Vaccinia virus-specific CD8+ T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans

Human Immunology

Volumn 69, Issue 12, 2008, Pages 815-825

  Terajima, Masanori ^a   Orphin, Laura ^a   Leporati, Anita M ^a   Pazoles, Pamela ^a   Cruz, John ^a   Rothman, Alan L ^a   Ennis, Francis A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

CD8+ T cell epitope; HLA supertype; Immunodominance; Poxvirus; Vaccinia virus

Indexed keywords

EPITOPE; HLA A1 ANTIGEN; HLA A2 ANTIGEN; HLA A24 ANTIGEN; HLA A3 ANTIGEN; HLA B44 ANTIGEN; HLA B7 ANTIGEN; SMALLPOX VACCINE; VACCINIA VACCINE;

ALLELE; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; HLA SYSTEM; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNIZATION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POXVIRUS; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION; VACCINIA VIRUS; VIRUS STRAIN;

ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; EPITOPE MAPPING; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; INTERFERON-GAMMA; PEPTIDES; SMALLPOX VACCINE; SPECIES SPECIFICITY; T-CELL ANTIGEN RECEPTOR SPECIFICITY; VACCINATION; VACCINIA; VACCINIA VIRUS;

EID: 57149139113     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.09.009     Document Type: Article

References (57)

1. Fenner F., Henderson D.A., Arita I., Jezek Z., and Ladnyi I.D. Smallpox and its eradication (1988), World Health Organization, Geneza, Switzerland
2. Esposito J.J., and Fenner F. Poxviruses. In: Knipe D.M., and Howley P.M. (Eds). Fields virology, vol 2 (2001), Lippincott Wiliams & Wilkins, Philadelphia 2885-2921
3. Fulginiti V.A., Kempe C.H., Hathaway W.E., Pearlman D.S., Serber Jr. O.F., Eller J.J., et al. Progressive vaccinia in immunologically deficient individuals. Birth Defects 4 (1968) 129-145
4. Kempe C.H. Acceptance of the Howland Award. Pediatr Res 14 (1980) 1155-1161
5. Freed E.R., Duma R.J., and Escobar M.R. Vaccinia necrosum and its relationship to impaired immunologic responsiveness. Am J Med 52 (1972) 411-420
6. Hansson O., Johansson S.G.O., and Vahlquist B. Vaccinia gangrenosa with normal humora antibodies. A case possibly due to deficient cellular immunity treated with N-methylisatin β-thiosemicarbazone (compound 33T57, Marboran). Acta Paediatr Scand 55 (1966) 264-272
7. Henderson D.A., Inglesby T.V., Bartlett J.G., Ascher M.S., Eitzen E., Jahrling P.B., et al. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. J Am Med Assoc 281 (1999) 2127-2137
8. Rosenthal S.R., Merchlinsky M., Kleppinger C., and Goldenthal K.L. Developing new smallpox vaccines. Emerg Infect Dis 7 (2001) 920-926
9. Carroll M.W., and Moss B. Poxviruses as expression vectors. Curr Opin Biotechnol 8 (1997) 573-577
10. Shen Y., and Nemunaitis J. Fighting cancer with vaccinia virus: teaching new tricks to an old dog. Mol Ther 11 (2005) 180-195
11. Drexler I., Staib C., Kastenmuller W., Stevanovic S., Schmidt B., Lemonnier F.A., et al. Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines. Proc Natl Acad Sci USA 100 (2003) 217-222
12. Terajima M., Cruz J., Raines G., Kilpatrick E.D., Kennedy J.S., Rothman A.L., et al. Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses. J Exp Med 197 (2003) 927-932
13. Snyder J.T., Belyakov I.M., Dzutsev A., Lemonnier F., and Berzofsky J.A. Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses. J Virol 78 (2004) 7052-7060
14. Oseroff C., Kos F., Bui H.H., Peters B., Pasquetto V., Glenn J., et al. HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation. Proc Natl Acad Sci USA 102 (2005) 13980-13985
15. Pasquetto V., Bui H.H., Giannino R., Mirza F., Sidney J., Oseroff C., et al. HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. J Immunol 175 (2005) 5504-5515
16. Jing L., Chong T.M., McClurkan C.L., Huang J., Story B.T., and Koelle D.M. Diversity in the acute CD8 T cell response to vaccinia virus in humans. J Immunol 175 (2005) 7550-7559
17. Terajima M., Cruz J., Leporati A.M., Demkowicz Jr. W.E., Kennedy J.S., and Ennis F.A. Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7. Hum Immunol 67 (2006) 512-520
18. Tang J., Murtadha M., Schnell M., Eisenlohr L.C., Hooper J., and Flomenberg P. Human T-cell responses to vaccinia virus envelope proteins. J Virol 80 (2006) 10010-10020
19. Sahin U., Tureci O., Graf C., Meyer R.G., Lennerz V., Britten C.M., et al. Rapid molecular dissection of viral and bacterial immunomes. Eur J Immunol 36 (2006) 1049-1057
20. Ostrout N.D., McHugh M.M., Tisch D.J., Moormann A.M., Brusic V., and Kazura J.W. Long-term T cell memory to human leucocyte antigen-A2 supertype epitopes in humans vaccinated against smallpox. Clin Exp Immunol 149 (2007) 265-273
21. Meyer R.G., Graf C., Britten C.M., Huber C., and Wolfel T. Rapid identification of an HLA-B*1501-restricted vaccinia peptide antigen. Vaccine 25 (2007) 4715-4722
22. Kennedy R., and Poland G.A. T-cell epitope discovery for variola and vaccinia viruses. Rev Med Virol 17 (2007) 93-113
23. Yewdell J.W., and Del Val M. Immunodominance in TCD8+ responses to viruses: cell biology, cellular immunology, and mathematical models. Immunity 21 (2004) 149-153
24. Tscharke D.C., Karupiah G., Zhou J., Palmore T., Irvine K.R., Haeryfar S.M., et al. Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines. J Exp Med 201 (2005) 95-104
25. Yewdell J.W. Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. Immunity 25 (2006) 533-543
26. Weltzin R., Liu J., Pugachev K.V., Myers G.A., Coughlin B., Blum P.S., et al. Clonal vaccinia virus grown in cell culture as a new smallpox vaccine. Nat Med 9 (2003) 1125-1130
27. Monath T.P., Caldwell J.R., Mundt W., Fusco J., Johnson C.S., Buller M., et al. ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)-a second-generation smallpox vaccine for biological defense. Int J Infect Dis 8 Suppl 2 (2004) S31-S44
28. Terajima M., Van Epps H.L., Li D., Leporati A.M., Juhlin S.E., Mustonen J., et al. Generation of recombinant vaccinia viruses expressing Puumala virus proteins and use in isolating cytotoxic T cells specific for Puumala virus. Virus Res 84 (2002) 67-77
29. Ennis F.A., Cruz J., Demkowicz Jr. W.E., Rothman A.L., and McClain D.J. Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination. J Infect Dis 185 (2002) 1657-1659
30. Terajima M., and Ennis F.A. Using HLA-transgenic mice to identify immunodominant human CD8+ T cell epitopes-does (genome) size matter?. Immunol Lett 105 (2006) 97-98
31. Antoine G., Scheiflinger F., Dorner F., and Falkner F.G. The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 244 (1998) 365-396
32. Li G., Chen N., Feng Z., Buller R.M., Osborne J., Harms T., et al. Genomic sequence and analysis of a vaccinia virus isolate from a patient with a smallpox vaccine-related complication. Virol J 3 (2006) 88
33. Sette A., and Sidney J. HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. Curr Opin Immunol 10 (1998) 478-482
34. Sette A., and Sidney J. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50 (1999) 201-212
35. Sidney J., Southwood S., and Sette A. Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires. Immunogenetics 57 (2005) 393-408
36. Sidney J., Peters B., Frahm N., Brander C., and Sette A. HLA class I supertypes: a revised and updated classification. BMC Immunol 9 (2008) 1
37. Smith C.L., Mirza F., Pasquetto V., Tscharke D.C., Palmowski M.J., Dunbar P.R., et al. Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara. J Immunol 175 (2005) 8431-8437
38. Woodberry T., Suscovich T.J., Henry L.M., Davis J.K., Frahm N., Walker B.D., et al. Differential targeting and shifts in the immunodominance of Epstein-Barr virus-specific CD8 and CD4 T cell responses during acute and persistent infection. J Infect Dis 192 (2005) 1513-1524
39. Boon A.C., de Mutsert G., Graus Y.M., Fouchier R.A., Sintnicolaas K., Osterhaus A.D., et al. The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype. J Virol 76 (2002) 582-590
40. Moss B. Poxviridae: the viruses and their replication. In: Knipe D.M., and Howley P.M. (Eds). Fields virology, vol 2 (2001), Lippincott Wiliams & Wilkins, Philadelphia 2849-2883
41. Kieff E., and Rickinson A.B. Epstein-Barr virus and its replication. In: Knipe D.M., and Howley P.M. (Eds). Fields virology, vol 2 (2001), Lippincott Williams & Wilkins, Philadelphia 2511-2573
42. Del Val M., Schlicht H.J., Ruppert T., Reddehase M.J., and Koszinowski U.H. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66 (1991) 1145-1153
43. Yellen-Shaw A.J., Wherry E.J., Dubois G.C., and Eisenlohr L.C. Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein. J Immunol 158 (1997) 3227-3234
44. Yellen-Shaw A.J., and Eisenlohr L.C. Regulation of class I-restricted epitope processing by local or distal flanking sequence. J Immunol 158 (1997) 1727-1733
45. Miller J.D., van der Most R.G., Akondy R.S., Glidewell J.T., Albott S., Masopust D., et al. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 28 (2008) 710-722
46. Reddehase M.J., and Koszinowski U.H. Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection. Nature 312 (1984) 369-371
47. Reddehase M.J. The immunogenicity of human and murine cytomegaloviruses. Curr Opin Immunol 12 (2000) 390-396
48. Assarsson E., Greenbaum J.A., Sundstrom M., Schaffer L., Hammond J.A., Pasquetto V., et al. Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes. Proc Natl Acad Sci USA 105 (2008) 2140-2145
49. Pascolo S. HLA class I transgenic mice: development, utilisation and improvement. Expert Opin Biol Ther 5 (2005) 919-938
50. Vitiello A., Marchesini D., Furze J., Sherman L.A., and Chesnut R.W. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J Exp Med 173 (1991) 1007-1015
51. Pascolo S., Bervas N., Ure J.M., Smith A.G., Lemonnier F.A., and Perarnau B. HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice. J Exp Med 185 (1997) 2043-2051
52. Pajot A., Michel M.L., Fazilleau N., Pancre V., Auriault C., Ojcius D.M., et al. A mouse model of human adaptive immune functions: HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice. Eur J Immunol 34 (2004) 3060-3069
53. Di Nicola M., Carlo-Stella C., Mortarini R., Baldassari P., Guidetti A., Gallino G.F., et al. Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanoma. Clin Cancer Res 10 (2004) 5381-5390
54. Benhnia M.R., McCausland M.M., Su H.P., Singh K., Hoffmann J., Davies D.H., et al. Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine. J Virol 82 (2008) 3751-3768
55. Dong Y., and Denny T.N. HLA-A2-restricted human CD8(+) cytotoxic T lymphocyte responses to a novel epitope in vaccinia virus that is conserved among orthopox viruses. J Infect Dis 194 (2006) 168-175
56. Parker K.C., Bednarek M.A., and Coligan J.E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 152 (1994) 163-175
57. Rammensee H., Bachmann J., Emmerich N.P., Bachor O.A., and Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50 (1999) 213-219